Kangmei Pharma | 600518 - Debt

Stock Price
1.91
Daily Change
-0.02 -1.04%
Monthly
-1.04%
Yearly
-12.79%
Q1 Forecast
1.85

Kangmei Pharma reported CNY131.64M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 44.59M 1.4M Jun/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Genomma Lab Internacional MXN 7.2B 242.7M Jun/2025
Hypermarcas BRL 8.86B 535.71M Jun/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Jiangsu Hengrui CNY 91.43M 17.24M Jun/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Sh Fosun Pharma CNY 36.99B 176.57M Jun/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.44B 318.8M Sep/2025
Wuxi Apptec CNY 7.52B 1.06B Jun/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025